The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation
Clinical trial NCT02581202 · COMPLETED
Trial details
- NCT number
- NCT02581202
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-12-21
- Primary completion
- 2017-05-27
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.